Copyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=arryLatest Financial News for Array BioPharma Inc.en-USTue, 21 May 2013 17:29:06 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifhttp://finance.yahoo.com/q/h?s=arry14445http://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=13vhi6npa/*http://seekingalpha.com/article/1450481-array-biopharma-s-ceo-presents-at-2013-ubs-global-life-sciences-conference-transcript?source=yahoo[at Seeking Alpha] - Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript)yahoo_finance/4128839529Tue, 21 May 2013 17:29:06 GMThttp://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=14aq1n2nn/*http://seekingalpha.com/article/1441571-array-biopharma-s-ceo-presents-at-bank-of-america-merrill-lynch-healthcare-conference-transcript?source=yahoo[at Seeking Alpha] - Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript)yahoo_finance/2087403333Thu, 16 May 2013 20:34:03 GMThttp://us.rd.yahoo.com/finance/external/bloomberg/rss/SIG=13ej46ljg/*http://www.bloomberg.com/news/2013-05-16/astrazeneca-advances-three-cancer-drugs-into-late-stage-trials.html?cmpid=yhooyahoo_finance/2378470231Thu, 16 May 2013 06:00:00 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13jqd7nnh/*http://seekingalpha.com/article/1438981-part-3-will-array-biopharma-become-a-late-stage-biopharmaceutical-company?source=yahooyahoo_finance/3055988132Thu, 16 May 2013 05:00:35 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-announces-clinical-data-120000331.html[PR Newswire] - BOULDER, Colo., May 15, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, MEK162 (licensed to Novartis) and selumetinib (licensed to AstraZeneca) ...yahoo_finance/3117180560Wed, 15 May 2013 12:00:00 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13fou1vel/*http://seekingalpha.com/article/1435851-array-biopharma-measuring-the-strength-of-this-small-cap-pharma-stock?source=yahooyahoo_finance/2625703511Wed, 15 May 2013 09:45:38 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=arryyahoo_finance/952524518Tue, 14 May 2013 17:04:28 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13j322bm4/*http://seekingalpha.com/article/1428191-part-2-will-array-biopharma-become-a-late-stage-biopharmaceutical-company?source=yahooyahoo_finance/605678369Sun, 12 May 2013 22:21:21 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13jttg26r/*http://seekingalpha.com/article/1428181-part-1-will-array-biopharma-become-a-late-stage-biopharmaceutical-company?source=yahooyahoo_finance/570749236Sun, 12 May 2013 22:06:09 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-present-bank-america-120000528.html[PR Newswire] - BOULDER, Colo., May 8, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare ...yahoo_finance/4113995422Wed, 08 May 2013 12:00:00 GMThttp://us.rd.yahoo.com/finance/external/xtrsa/rss/SIG=13i42q802/*http://seekingalpha.com/article/1410361-array-biopharma-s-ceo-discusses-q3-2013-results-earnings-call-transcript?source=yahoo[at Seeking Alpha] - Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcriptyahoo_finance/1556944162Tue, 07 May 2013 19:32:07 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130507/arry10-q.htmlyahoo_finance/655264217Tue, 07 May 2013 14:16:56 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13jl6mg59/*http://seekingalpha.com/article/1407291-near-term-catalysts-and-high-insider-ownership-make-gtx-an-attractive-buy?source=yahooyahoo_finance/3475708118Tue, 07 May 2013 13:01:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/cc/2/138522.htmlyahoo_finance/2206913388Tue, 07 May 2013 13:00:00 GMThttp://us.rd.yahoo.com/finance/external/xwscheats/rss/SIG=12v0er6a6/*http://wallstcheatsheet.com/stocks/array-biopharma-earnings-heres-why-shares-are-up-now.html/?ref=YFyahoo_finance/3723628019Mon, 06 May 2013 22:01:03 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-reports-financial-results-200500748.html[PR Newswire] - BOULDER, Colo., May 6, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the third quarter of its fiscal year ending June 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO ...yahoo_finance/2197878577Mon, 06 May 2013 20:05:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-biopharma-initiate-phase-3-200444686.htmlyahoo_finance/3717803660Mon, 06 May 2013 20:04:44 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/array-announces-global-phase-3-200000691.html[PR Newswire] - BOULDER, Colo., May 6, 2013 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that it will initiate a global Phase 3 clinical trial in patients with recurrent low-grade serous ovarian ...yahoo_finance/3371935893Mon, 06 May 2013 20:00:00 GMThttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125n4tl23/*http://www.noodls.com/view/62E295155B00C85A1CBFADFC8FBD60E7F0E46B3E[at noodls] - -Pivotal trials in patients with NRAS mutant melanoma expected to begin in 2013- -Also pursuing MEK/Raf combination in BRAF melanoma- Boulder, Colo., (November 8, 2012) - At its R&D Investor event earlier ...yahoo_finance/3981920542Thu, 08 Nov 2012 22:11:26 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://au.finance.yahoo.com/news/healthcare-review-genworth-laboratory-corp-030500518.html[ACN Newswire] - Vancouver, BC, Aug 2, 2012 - (ACN Newswire) - U.S. Stocks were trading mostly higher on Wednesday in cautious trading following mixed economic data did little to change views of the Federal Reserve's policy ...yahoo_finance/1289495353Thu, 02 Aug 2012 03:05:00 GMT